In a mere 8 years we have developed two clinical drug candidates and built an innovative and efficient research platform. Our secret: a new pharmacological class, an innovative approach to drug development, and the utmost dedication of our team.
“
Pier Vincenzo
Piazza
CEO
+
Valérie
Scappaticci
CFO
” Thinking outside the box is the secret of our success: Aelis Farma is an exciting journey through science and innovation. “
+
Stéphanie
Monlezun
COO
” At Aelis Farma, we have one goal: transform innovation into reliable therapeutic solutions for diseases with unmet medical needs. “
+
Management Team
Pier Vincenzo
Piazza
CEO
+
Valérie
Scappaticci
CFO
+
Stéphanie
Monlezun
COO
+
Board of Directors
+
Anders Gersel
Pedersen
Chairman of the Board
+
Pier Vincenzo
Piazza
Director and CEO
+
Brahim
Guetarni
Director
+
Karina
Hansen
Independent Director
+
Karen
Linehan
Independent Director
+
Irina
Staatz-Granzer
Independent Director
+
François
Thomas
Non-voting Director
Scientific Advisory Board
+
Robert Malenka
Chairman of the Scientific Advisory Board
Professor and Deputy Director of the Neurosciences Institute (Stanford University)
+
Keith Humphreys
Professor and Section Director for Mental Health Policy, Department of Psychiatry (Stanford University)
+
Daniele Piomelli
Professor at the University of California Irvine (UCI), Former Director of Drug Discovery and Development IIT
+
Markus Heilig
Director, Center for Social and Affective Neuroscience, Linköping University (Sweden) Former Clinical Research Director at NIAAA within America’s National Institute of Health (NIH)